ARTIVION, INC. Amortization of Intangible Assets
ARTIVION, INC. (AORT) reported Amortization of Intangible Assets of $4.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-07
- ARTIVION, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $4.23M, a 23.31% increase year-over-year.
- ARTIVION, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $3.91M, a 15.44% increase year-over-year.
- ARTIVION, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $3.48M, a 17.15% decline year-over-year.
- ARTIVION, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $3.48M, a 12.88% decline year-over-year.
- ARTIVION, INC. amortization of intangible assets for fiscal 2025 was $13.78M, a 13.12% decline from fiscal 2024.
- ARTIVION, INC. amortization of intangible assets for fiscal 2024 was $15.86M, a 4.32% increase from fiscal 2023.
- ARTIVION, INC. amortization of intangible assets for fiscal 2023 was $15.20M, a 0.73% decline from fiscal 2022.
- ARTIVION, INC. amortization of intangible assets for fiscal 2022 was $15.31M, a 8.98% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.23M 10-Q · filed 2026-08-07 | $8.14M 10-Q · filed 2026-08-07 | $11.62M derived: sum of 3 quarters · filed 2026-08-07 | $15.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $3.91M 10-Q · filed 2026-05-08 | $7.39M derived: sum of 2 quarters · filed 2026-05-08 | $10.87M derived: sum of 3 quarters · filed 2026-05-08 | $14.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $6.96M derived: sum of 2 quarters · filed 2026-02-18 | $10.39M derived: sum of 3 quarters · filed 2026-08-07 | $13.78M 10-K · filed 2026-02-18 |
| 2025-09-30 | $3.48M 10-Q · filed 2025-11-07 | $6.90M derived: sum of 2 quarters · filed 2026-08-07 | $10.29M 10-Q · filed 2025-11-07 | $14.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $3.43M 10-Q · filed 2026-08-07 | $6.82M 10-Q · filed 2026-08-07 | $11.02M derived: sum of 3 quarters · filed 2026-08-07 | $15.01M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $3.39M 10-Q · filed 2026-05-08 | $7.59M derived: sum of 2 quarters · filed 2026-05-08 | $11.58M derived: sum of 3 quarters · filed 2026-05-08 | $15.38M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $8.20M derived: sum of 2 quarters · filed 2026-02-18 | $11.99M derived: sum of 3 quarters · filed 2026-02-18 | $15.86M 10-K · filed 2026-02-18 |
| 2024-09-30 | $3.99M 10-Q · filed 2025-11-07 | $7.78M derived: sum of 2 quarters · filed 2025-11-07 | $11.65M 10-Q · filed 2025-11-07 | $15.39M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-30 | $3.79M 10-Q · filed 2025-08-08 | $7.66M 10-Q · filed 2025-08-08 | $11.40M derived: sum of 3 quarters · filed 2026-02-18 | $15.17M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-31 | $3.87M 10-Q · filed 2025-05-06 | $7.61M derived: sum of 2 quarters · filed 2026-02-18 | $11.38M derived: sum of 3 quarters · filed 2026-02-18 | $15.18M derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-31 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $7.51M derived: sum of 2 quarters · filed 2026-02-18 | $11.32M derived: sum of 3 quarters · filed 2026-02-18 | $15.20M 10-K · filed 2026-02-18 |
| 2023-09-30 | $3.77M 10-Q · filed 2024-11-08 | $7.57M derived: sum of 2 quarters · filed 2024-11-08 | $11.45M 10-Q · filed 2024-11-08 | $15.09M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $3.81M 10-Q · filed 2024-08-09 | $7.69M 10-Q · filed 2024-08-09 | $11.32M derived: sum of 3 quarters · filed 2025-02-28 | $15.01M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $3.88M 10-Q · filed 2024-05-07 | $7.52M derived: sum of 2 quarters · filed 2025-02-28 | $11.20M derived: sum of 3 quarters · filed 2025-02-28 | $15.11M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $7.32M derived: sum of 2 quarters · filed 2025-02-28 | $11.23M derived: sum of 3 quarters · filed 2025-02-28 | $15.31M 10-K · filed 2025-02-28 |
| 2022-09-30 | $3.69M 10-Q · filed 2023-11-03 | $7.59M derived: sum of 2 quarters · filed 2023-11-03 | $11.68M 10-Q · filed 2023-11-03 | $15.79M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $3.90M 10-Q · filed 2023-08-04 | $7.99M 10-Q · filed 2023-08-04 | $12.11M derived: sum of 3 quarters · filed 2024-02-23 | $16.31M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $4.08M 10-Q · filed 2023-05-05 | $8.20M derived: sum of 2 quarters · filed 2024-02-23 | $12.41M derived: sum of 3 quarters · filed 2024-02-23 | $16.64M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $4.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $8.32M derived: sum of 2 quarters · filed 2024-02-23 | $12.56M derived: sum of 3 quarters · filed 2024-02-23 | $16.82M 10-K · filed 2024-02-23 |
| 2021-09-30 | $4.20M 10-Q · filed 2022-11-04 | $8.44M derived: sum of 2 quarters · filed 2022-11-04 | $12.70M 10-Q · filed 2022-11-04 | $17.04M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $4.24M 10-Q · filed 2022-08-05 | $8.50M 10-Q · filed 2022-08-05 | $12.83M derived: sum of 3 quarters · filed 2023-02-23 | $16.23M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $4.26M 10-Q · filed 2022-05-06 | $8.59M derived: sum of 2 quarters · filed 2023-02-23 | $11.99M derived: sum of 3 quarters · filed 2023-02-23 | $14.99M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $7.73M derived: sum of 2 quarters · filed 2023-02-23 | $10.73M derived: sum of 3 quarters · filed 2023-02-23 | $13.76M 10-K · filed 2023-02-23 |
| 2020-09-30 | $3.40M 10-Q · filed 2021-11-05 | $6.40M derived: sum of 2 quarters · filed 2021-11-05 | $9.43M 10-Q · filed 2021-11-05 | $12.48M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $3.00M 10-Q · filed 2021-07-30 | $6.03M 10-Q · filed 2021-07-30 | $9.09M derived: sum of 3 quarters · filed 2022-02-22 | $11.75M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $3.03M 10-Q · filed 2021-04-30 | $6.09M derived: sum of 2 quarters · filed 2022-02-22 | $8.75M derived: sum of 3 quarters · filed 2022-02-22 | $11.30M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $5.71M derived: sum of 2 quarters · filed 2022-02-22 | $8.27M derived: sum of 3 quarters · filed 2022-02-22 | $10.85M 10-K · filed 2022-02-22 |
| 2019-09-30 | $2.66M 10-Q · filed 2020-11-05 | $5.22M derived: sum of 2 quarters · filed 2020-11-05 | $7.80M 10-Q · filed 2020-11-05 | $10.39M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $2.56M 10-Q · filed 2020-07-31 | $5.14M 10-Q · filed 2020-07-31 | $7.73M derived: sum of 3 quarters · filed 2021-02-23 | $10.44M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $2.58M 10-Q · filed 2020-05-01 | $5.18M derived: sum of 2 quarters · filed 2021-02-23 | $7.88M derived: sum of 3 quarters · filed 2021-02-23 | $10.64M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $5.30M derived: sum of 2 quarters · filed 2021-02-23 | $8.06M derived: sum of 3 quarters · filed 2021-02-23 | $10.79M 10-K · filed 2021-02-23 |
| 2018-09-30 | $2.71M 10-Q · filed 2019-10-31 | $5.46M derived: sum of 2 quarters · filed 2019-10-31 | $8.20M 10-Q · filed 2019-10-31 | $9.86M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $2.75M 10-Q · filed 2019-07-31 | $5.49M 10-Q · filed 2019-07-31 | $7.15M derived: sum of 3 quarters · filed 2020-02-19 | $8.29M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $2.73M 10-Q · filed 2019-05-02 | $4.40M derived: sum of 2 quarters · filed 2020-02-19 | $5.54M derived: sum of 3 quarters · filed 2020-02-19 | $6.68M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $2.80M derived: sum of 2 quarters · filed 2020-02-19 | $3.94M derived: sum of 3 quarters · filed 2020-02-19 | $5.08M 10-K · filed 2020-02-19 |
| 2017-09-30 | $1.14M 10-Q · filed 2018-11-01 | $2.28M derived: sum of 2 quarters · filed 2018-11-01 | $3.42M 10-Q · filed 2018-11-01 | $4.58M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $1.14M 10-Q · filed 2018-08-07 | $2.28M 10-Q · filed 2018-08-07 | $3.44M derived: sum of 3 quarters · filed 2019-02-26 | $4.59M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $1.14M 10-Q · filed 2018-05-04 | $2.29M derived: sum of 2 quarters · filed 2019-02-26 | $3.45M derived: sum of 3 quarters · filed 2019-02-26 | $4.61M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $2.31M derived: sum of 2 quarters · filed 2019-02-26 | $3.46M derived: sum of 3 quarters · filed 2019-02-26 | $4.43M 10-K · filed 2019-02-26 |
| 2016-09-30 | $1.16M 10-Q · filed 2017-10-31 | $2.31M derived: sum of 2 quarters · filed 2017-10-31 | $3.27M 10-Q · filed 2017-10-31 | $3.89M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | $1.16M 10-Q · filed 2017-07-25 | $2.12M 10-Q · filed 2017-07-25 | $2.73M derived: sum of 3 quarters · filed 2018-03-09 | $3.24M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | $962.00K 10-Q · filed 2017-04-27 | $1.58M derived: sum of 2 quarters · filed 2018-03-09 | $2.08M derived: sum of 3 quarters · filed 2018-03-09 | $2.58M derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | $615.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $1.12M derived: sum of 2 quarters · filed 2018-03-09 | $1.62M derived: sum of 3 quarters · filed 2018-03-09 | $2.13M 10-K · filed 2018-03-09 |
| 2015-09-30 | $503.00K 10-Q · filed 2016-10-27 | $1.00M derived: sum of 2 quarters · filed 2016-10-27 | $1.52M 10-Q · filed 2016-10-27 | $2.04M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-06-30 | $502.00K 10-Q · filed 2016-07-26 | $1.02M 10-Q · filed 2016-07-26 | $1.54M derived: sum of 3 quarters · filed 2017-02-16 | $2.04M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-03-31 | $515.00K 10-Q · filed 2016-04-29 | $1.04M derived: sum of 2 quarters · filed 2017-02-16 | $1.54M derived: sum of 3 quarters · filed 2017-02-16 | $2.05M derived: sum of 4 quarters · filed 2017-02-16 |
| 2014-12-31 | $524.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $1.03M derived: sum of 2 quarters · filed 2017-02-16 | $1.53M derived: sum of 3 quarters · filed 2017-02-16 | $2.03M 10-K · filed 2017-02-16 |
| 2014-09-30 | $504.00K 10-Q · filed 2015-10-27 | $1.01M derived: sum of 2 quarters · filed 2015-10-27 | $1.50M 10-Q · filed 2015-10-27 | $1.99M derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-06-30 | $503.00K 10-Q · filed 2015-07-28 | $999.00K 10-Q · filed 2015-07-28 | $1.49M derived: sum of 3 quarters · filed 2016-02-16 | $1.98M derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-03-31 | $496.00K 10-Q · filed 2015-04-29 | $987.00K derived: sum of 2 quarters · filed 2016-02-16 | $1.48M derived: sum of 3 quarters · filed 2016-02-16 | $1.99M derived: sum of 4 quarters · filed 2016-02-16 |
| 2013-12-31 | $491.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | $984.00K derived: sum of 2 quarters · filed 2016-02-16 | $1.49M derived: sum of 3 quarters · filed 2016-02-16 | $2.01M 10-K · filed 2016-02-16 |
| 2013-09-30 | $493.00K 10-Q · filed 2014-10-28 | $1.00M derived: sum of 2 quarters · filed 2014-10-28 | $1.51M 10-Q · filed 2014-10-28 | $2.03M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $508.00K 10-Q · filed 2014-07-24 | $1.02M 10-Q · filed 2014-07-24 | $1.54M derived: sum of 3 quarters · filed 2015-02-17 | $2.06M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $514.00K 10-Q · filed 2014-04-30 | $1.03M derived: sum of 2 quarters · filed 2015-02-17 | $1.55M derived: sum of 3 quarters · filed 2015-02-17 | $2.03M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $517.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $1.04M derived: sum of 2 quarters · filed 2015-02-17 | $1.51M derived: sum of 3 quarters · filed 2015-02-17 | $1.97M 10-K · filed 2015-02-17 |
| 2012-09-30 | $521.00K 10-Q · filed 2013-10-29 | $995.00K derived: sum of 2 quarters · filed 2013-10-29 | $1.45M 10-Q · filed 2013-10-29 | $1.91M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | $474.00K 10-Q · filed 2013-07-25 | $933.00K 10-Q · filed 2013-07-25 | $1.39M derived: sum of 3 quarters · filed 2014-02-21 | $1.82M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | $459.00K 10-Q · filed 2013-04-30 | $912.00K derived: sum of 2 quarters · filed 2014-02-21 | $1.35M derived: sum of 3 quarters · filed 2014-02-21 | $1.65M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | $453.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $889.00K derived: sum of 2 quarters · filed 2014-02-21 | $1.20M derived: sum of 3 quarters · filed 2014-02-21 | $1.37M 10-K · filed 2014-02-21 |
| 2011-09-30 | $436.00K 10-Q · filed 2012-10-30 | $742.00K derived: sum of 2 quarters · filed 2012-10-30 | $917.00K 10-Q · filed 2012-10-30 | |
| 2011-06-30 | $306.00K 10-Q · filed 2012-07-31 | $481.00K 10-Q · filed 2012-07-31 | ||
| 2010-12-31 | $571.00K 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |